These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prophylactic Oral Dextrose Gel for Newborn Babies at Risk of Neonatal Hypoglycaemia: A Randomised Controlled Dose-Finding Trial (the Pre-hPOD Study). Hegarty JE; Harding JE; Gamble GD; Crowther CA; Edlin R; Alsweiler JM PLoS Med; 2016 Oct; 13(10):e1002155. PubMed ID: 27780197 [TBL] [Abstract][Full Text] [Related]
4. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial. Harris DL; Weston PJ; Signal M; Chase JG; Harding JE Lancet; 2013 Dec; 382(9910):2077-83. PubMed ID: 24075361 [TBL] [Abstract][Full Text] [Related]
5. Computer-determined dosage of insulin in the management of neonatal hyperglycaemia (HINT2): protocol of a randomised controlled trial. Alsweiler J; Williamson K; Bloomfield F; Chase G; Harding J BMJ Open; 2017 Mar; 7(3):e012982. PubMed ID: 28264826 [TBL] [Abstract][Full Text] [Related]
6. Oral dextrose gel for the treatment of hypoglycaemia in newborn infants. Weston PJ; Harris DL; Battin M; Brown J; Hegarty JE; Harding JE Cochrane Database Syst Rev; 2016 May; (5):CD011027. PubMed ID: 27142842 [TBL] [Abstract][Full Text] [Related]
7. Protecting against brain damage by improving treatment in neonates with hypoglycaemia: ProBrain-D-a study protocol of a prospective longitudinal study. Hoermann H; Roeper M; Dafsari RS; Koestner F; Schneble D; von Zezschwitz D; Mayatepek E; Kummer S; Meissner T BMJ Open; 2022 Aug; 12(8):e063009. PubMed ID: 35985774 [TBL] [Abstract][Full Text] [Related]
8. Variations in New Zealand and Australian guidelines for the management of neonatal hypoglycaemia: A secondary analysis from the hypoglycaemia Prevention with Oral Dextrose gel Trial (hPOD). Rajay AB; Harding JE; J Paediatr Child Health; 2022 May; 58(5):820-829. PubMed ID: 34866258 [TBL] [Abstract][Full Text] [Related]
9. Incorporating dextrose gel and feeding in the treatment of neonatal hypoglycaemia. Gregory K; Turner D; Benjamin CN; Monthe-Dreze C; Johnson L; Hurwitz S; Wolfsdorf J; Sen S Arch Dis Child Fetal Neonatal Ed; 2020 Jan; 105(1):45-49. PubMed ID: 31079067 [TBL] [Abstract][Full Text] [Related]
10. Midwife or doctor local opinion leader to implement a national guideline in babies on postnatal wards (DesIGN): protocol of a cluster-randomised, blinded, controlled trial. Alsweiler JM; Crowther CA; Harding JE BMJ Open; 2017 Nov; 7(11):e017516. PubMed ID: 29170288 [TBL] [Abstract][Full Text] [Related]
11. Randomised trial of neonatal hypoglycaemia prevention with oral dextrose gel (hPOD): study protocol. Harding JE; Hegarty JE; Crowther CA; Edlin R; Gamble G; Alsweiler JM BMC Pediatr; 2015 Sep; 15():120. PubMed ID: 26377909 [TBL] [Abstract][Full Text] [Related]
12. Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects. Balachandran B; Mukhopadhyay K; Sachdeva N; Walia R; Attri SV Acta Paediatr; 2018 Jun; 107(6):990-995. PubMed ID: 29385640 [TBL] [Abstract][Full Text] [Related]
13. (Rad 8)Caffeine prophylaxis to improve intermittent hypoxaemia in infants born late preterm: a randomised controlled dosage trial (Latte Dosage Trial). Oliphant EA; McKinlay CJD; McNamara DG; Alsweiler JM BMJ Open; 2020 Oct; 10(10):e038271. PubMed ID: 33082191 [TBL] [Abstract][Full Text] [Related]
14. Paradoxical hypoglycaemia associated with diazoxide therapy for hyperinsulinaemic hypoglycaemia. Ponmani C; Gannon H; Hussain K; Senniappan S Horm Res Paediatr; 2013; 80(2):129-33. PubMed ID: 23886961 [TBL] [Abstract][Full Text] [Related]
15. [Oral glucose in neonates with an increased risk of neonatal hypoglycaemia halves the number of neonates receiving intravenous glucose]. Austie FMC; van Unen HJ; Smit-Wu MN; Bekhof J Ned Tijdschr Geneeskd; 2021 Mar; 165():. PubMed ID: 33720562 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of oral dextrose gel for prevention of neonatal hypoglycemia (hPOD): A multicenter, double-blind randomized controlled trial. Harding JE; Hegarty JE; Crowther CA; Edlin RP; Gamble GD; Alsweiler JM; PLoS Med; 2021 Jan; 18(1):e1003411. PubMed ID: 33507929 [TBL] [Abstract][Full Text] [Related]
17. Outcome at 4.5 years after dextrose gel treatment of hypoglycaemia: follow-up of the Sugar Babies randomised trial. Harris DL; Gamble GD; Harding JE; Arch Dis Child Fetal Neonatal Ed; 2023 Mar; 108(2):121-128. PubMed ID: 35940872 [TBL] [Abstract][Full Text] [Related]
18. Effect of diazoxide or glucagon on hepatic glucose production rate during extreme neonatal hypoglycaemia. Mehta A; Wootton R; Cheng KN; Penfold P; Halliday D; Stacey TE Arch Dis Child; 1987 Sep; 62(9):924-30. PubMed ID: 3314727 [TBL] [Abstract][Full Text] [Related]
19. Implementation of dextrose gel in the management of neonatal hypoglycaemia. Ter M; Halibullah I; Leung L; Jacobs S J Paediatr Child Health; 2017 Apr; 53(4):408-411. PubMed ID: 27862529 [TBL] [Abstract][Full Text] [Related]
20. Dextrose gel treatment does not impair subsequent feeding. Weston PJ; Harris DL; Harding JE Arch Dis Child Fetal Neonatal Ed; 2017 Nov; 102(6):F539-F541. PubMed ID: 28536206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]